Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03731832 · COMPLETED
Trial details
- NCT number
- NCT03731832
- Sponsor
- GWT-TUD GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-20
- Primary completion
- 2024-04-22
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.